Voyager Therapeutics (VYGR) Treasury Shares (2014 - 2026)

Voyager Therapeutics' Treasury Shares history runs 13 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Treasury Shares fell 25.99% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 25.99% YoY), while the FY2025 annual figure was $2.3 million, up 39.21% from the prior year.
• Treasury Shares came in at $2.1 million for Q1 2026 at Voyager Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.8 million in Q1 2025 to a low of $941275.0 in Q3 2022.
• A 5-year average of $1.7 million and a median of $1.6 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares sank 31.7% in 2022 and jumped 65.72% in 2025, its largest moves.
• Voyager Therapeutics' Treasury Shares stood at $1.1 million in 2022, then advanced by 23.22% to $1.4 million in 2023, then rose by 20.35% to $1.6 million in 2024, then surged by 39.21% to $2.3 million in 2025, then decreased by 8.2% to $2.1 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.1 million, $2.3 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison